Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 1416990-08-3
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Lenalidomide-OH features a hydroxyl-modified imide scaffold that enhances solubility and metabolic stability compared to parent lenalidomide. This derivative integrates readily into targeted protein degradation workflows, offering improved handling under standard bench conditions while maintaining potent immunomodulatory activity.
Lenalidomide-OH serves as a key synthetic intermediate for immunomodulatory drug derivatives, enabling straightforward access to the thalidomide scaffold. Its hydroxyl functionality enhances solubility and provides a handle for further functionalization via esterification or coupling reactions. The compound exhibits bench stability and compatibility with standard peptide and heterocyclic synthesis protocols, facilitating efficient route development in medicinal chemistry campaigns targeting hematological malignancies.
|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H315-H319-H335
|
|
|
Precautionary Statements : P233-P261-P264-P271-P280-P302+P352-P304+P340-P362-P405-P501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: